Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 8917.53 | 89 / 89 | 100% | 232.23 | 899 / 901 |
brain | 100% | 4761.13 | 2632 / 2642 | 100% | 140.18 | 705 / 705 |
adrenal gland | 100% | 203852.38 | 258 / 258 | 99% | 550.03 | 227 / 230 |
thymus | 100% | 3703.26 | 652 / 653 | 95% | 80.71 | 577 / 605 |
ovary | 100% | 4378.08 | 180 / 180 | 92% | 66.73 | 397 / 430 |
lung | 100% | 4967.62 | 578 / 578 | 91% | 90.38 | 1049 / 1155 |
uterus | 99% | 3642.89 | 169 / 170 | 90% | 93.41 | 413 / 459 |
bladder | 100% | 5369.86 | 21 / 21 | 86% | 143.84 | 433 / 504 |
skin | 87% | 3919.73 | 1577 / 1809 | 96% | 104.46 | 454 / 472 |
breast | 100% | 4159.61 | 458 / 459 | 78% | 33.95 | 876 / 1118 |
pancreas | 76% | 1225.21 | 250 / 328 | 97% | 71.69 | 172 / 178 |
esophagus | 95% | 2839.43 | 1368 / 1445 | 78% | 54.76 | 143 / 183 |
stomach | 100% | 2922.81 | 359 / 359 | 64% | 29.97 | 183 / 286 |
intestine | 100% | 3448.15 | 964 / 966 | 49% | 27.06 | 260 / 527 |
prostate | 99% | 2994.03 | 242 / 245 | 45% | 14.60 | 228 / 502 |
adipose | 100% | 4861.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 99.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 134.16 | 29 / 29 |
muscle | 100% | 10836.00 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4875.94 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.76 | 1 / 1 |
blood vessel | 99% | 3412.99 | 1321 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 7939.54 | 851 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 54.98 | 42 / 45 |
peripheral blood | 71% | 2312.11 | 664 / 929 | 0% | 0 | 0 / 0 |
liver | 12% | 188.92 | 26 / 226 | 29% | 20.90 | 117 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0044597 | Biological process | daunorubicin metabolic process |
GO_0003091 | Biological process | renal water homeostasis |
GO_0044598 | Biological process | doxorubicin metabolic process |
GO_0019853 | Biological process | L-ascorbic acid biosynthetic process |
GO_0035809 | Biological process | regulation of urine volume |
GO_0072205 | Biological process | metanephric collecting duct development |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006700 | Biological process | C21-steroid hormone biosynthetic process |
GO_0002070 | Biological process | epithelial cell maturation |
GO_0071475 | Biological process | cellular hyperosmotic salinity response |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0006693 | Biological process | prostaglandin metabolic process |
GO_0046370 | Biological process | fructose biosynthetic process |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0047655 | Molecular function | allyl-alcohol dehydrogenase activity |
GO_0004032 | Molecular function | aldose reductase (NADPH) activity |
GO_0043795 | Molecular function | glyceraldehyde oxidoreductase activity |
GO_0009055 | Molecular function | electron transfer activity |
GO_0001758 | Molecular function | retinal dehydrogenase activity |
GO_0036130 | Molecular function | prostaglandin H2 endoperoxidase reductase activity |
GO_0052650 | Molecular function | all-trans-retinol dehydrogenase (NADP+) activity |
GO_0047939 | Molecular function | L-glucuronate reductase activity |
GO_0047956 | Molecular function | glycerol dehydrogenase (NADP+) activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AKR1B1 |
Protein name | Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21) Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase) |
Synonyms | ALR2 ALDR1 |
Description | FUNCTION: Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols. Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosacharides, bile acids and xenobiotics substrates. Key enzyme in the polyol pathway, catalyzes reduction of glucose to sorbitol during hyperglycemia . Reduces steroids and their derivatives and prostaglandins. Displays low enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal . Catalyzes the reduction of diverse phospholipid aldehydes such as 1-palmitoyl-2-(5-oxovaleroyl)-sn -glycero-3-phosphoethanolamin (POVPC) and related phospholipid aldehydes that are generated from the oxydation of phosphotidylcholine and phosphatdyleethanolamides . Plays a role in detoxifying dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal and their glutathione-conjugates carbonyls (GS-carbonyls) . . |
Accessions | E9PEF9 E9PCX2 ENST00000426422.1 ENST00000434222.5 P15121 ENST00000285930.9 |